发明申请
US20110319451A1 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders
审中-公开
5-Ht6受体及其调节剂用于治疗胰岛素相关性疾病
- 专利标题: 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders
- 专利标题(中): 5-Ht6受体及其调节剂用于治疗胰岛素相关性疾病
-
申请号: US13055128申请日: 2009-07-22
-
公开(公告)号: US20110319451A1公开(公告)日: 2011-12-29
- 发明人: James N. Leonard , Zhi-Liang Chu , Brian M. Smith
- 申请人: James N. Leonard , Zhi-Liang Chu , Brian M. Smith
- 国际申请: PCT/US2009/004247 WO 20090722
- 主分类号: A61K31/4439
- IPC分类号: A61K31/4439 ; A61P3/10 ; C12Q1/02 ; A61P3/04 ; A61P3/08 ; A61P5/48 ; A61P3/06
摘要:
The present invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. In addition, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a single dose of a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. Further, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor in an isolated cell, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound.
信息查询
IPC分类: